Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis [Phase 4]
Phase 4 clinical trial evaluating the impact of SGLT-2 inhibitors on albuminuria in chronic kidney disease patients with lupus nephritis and…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: The Safety, Efficacy, and Cellular Metabolic Kinetics of CT1192 in Treating Patients With Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis [Phase 1]
Phase 1 clinical trial evaluating CT1192 for safety, efficacy, and cellular metabolic kinetics in ANCA-associated vasculitis; the study stat…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases [Phase 1]
Phase 1 clinical trial evaluating a BCMA/CD19 dual-targeted CAR-T cell therapy for autoimmune kidney diseases, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis [NA]
A completed clinical trial from University Hospital, Bordeaux investigates the role of soluble CD95 ligand in the pathophysiology of ANCA-as…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV [EARLY_Phase 1]
This update covers an early-phase Phase 1 trial of RD06-04, a targeted CD19 universal CAR-T cell therapy, for idiopathic inflammatory myopat…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating OL-108 in relapsed/refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial [Phase 3]
A Phase 3 clinical trial (RENATO) evaluating pioglitazone to promote renal tolerance in ANCA-associated vasculitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis [Phase 4]
This update describes a Phase 4 trial evaluating avacopan versus reduced-dose glucocorticoids in ANCA-associated vasculitis, which is curren…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
This entry describes the Armenian nationwide registry of systemic autoimmune and autoinflammatory diseases, which is currently recruiting pa…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of universal CD19 CAR-T cells (UWD-CD19) with immunosuppressants for refractory auto…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
This clinical trial update describes a study aiming to predict diverse glucocorticoid toxicity outcomes across inflammatory rheumatic diseas…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Avacostar - (PASS)
Phase 4 PASS trial for Avacostar in ANCA-associated vasculitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Early-access Avacopan in Real-world ANCA-associated Vasculitis
This entry provides information about an early-access program for avacopan in real-world ANCA-associated vasculitis, and notes that the stud…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV
A pediatric clinical trial is assessing the therapeutic efficacy of anti-CD19 CAR-T cells in children with refractory ANCA-associated vascul…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]
A clinical trial update shows BRL-301 universal CAR-T cells from Bioray Laboratories enrolling (by invitation) for relapse or refractory aut…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Rare AutoImmune SElf-management Programme Development
This document reports a clinical trial development for a Rare Autoimmune Self-management Programme, currently recruiting across several auto…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating an anti-CD19 CAR-T cell therapy for ANCA-associated vasculitis, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
A recruiting clinical study evaluating the role of platelets in the pathophysiology of systemic lupus erythematosus. The study also presents…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Biocollection of Patients With ANCA Associated Vasculitis [NA]
A clinical trial update describing a biocollection study enrolling patients with ANCA-associated vasculitis; the study is currently recruiti…